Transformed Indolent Lymphoma
2 clinical trials · Condition
◉ Watch Transformed Indolent Lymphoma
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT02653989) | Medivation, Inc. | 2016-12-01 |
| Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL (NCT02747732) | Meirav Kedmi MD | 2016-12-01 |
Track Transformed Indolent Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.